Literature DB >> 15477563

Ventriculoperitoneal shunting for idiopathic intracranial hypertension.

Gunnel Bynke1, Göran Zemack, Hans Bynke, Bertil Romner.   

Abstract

Seventeen patients treated with ventriculoperitoneal shunt (VPS) for idiopathic intracranial hypertension (IIH) were followed up for 1.8 to 12.8 years (mean 6.5 years). The ventricular catheter was inserted without any guidance device. VPS was effective on all clinical manifestations of IIH. Seven patients required one or two (a total of nine) surgical revisions. The revision rate was significantly less than in two similar series of patients treated with lumboperitoneal shunt.

Entities:  

Mesh：

Year:  2004        PMID： 15477563     DOI： 10.1212/01.wnl.0000140699.43019.48

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  22 in total

1.  Visual Outcomes from Shunting for Idiopathic Intracranial Hypertension.

Authors:  S J Hickman; N Raoof; H Panesar; J M McMullan; I M Pepper; B Sharrack
Journal:  Neuroophthalmology       Date:  2014-11-12

Review 2.  Headache attributable to nonvascular intracranial disorders.

Authors:  Mark Obermann; Dagny Holle; Steffen Naegel; Hans-Christoph Diener
Journal:  Curr Pain Headache Rep       Date:  2011-08

3.  Perimetry, retinal nerve fiber layer thickness and papilledema grade after cerebrospinal fluid shunting in patients with idiopathic intracranial hypertension.

Authors:  Jennifer L Rizzo; Khoa V Lam; Michael Wall; Machelle D Wilson; John L Keltner
Journal:  J Neuroophthalmol       Date:  2015-03       Impact factor: 3.042

4.  Long-Term Results of Optic Nerve Sheath Fenestration for Idiopathic Intracranial Hypertension: Earlier Intervention Favours Improved Outcomes.

Authors:  Stacy L Pineles; Nicholas J Volpe
Journal:  Neuroophthalmology       Date:  2013-01-29

5.  Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study.

Authors:  Alexandra J Sinclair; Michael A Burdon; Peter G Nightingale; Alexandra K Ball; Peter Good; Timothy D Matthews; Andrew Jacks; Mark Lawden; Carl E Clarke; Paul M Stewart; Elizabeth A Walker; Jeremy W Tomlinson; Saaeha Rauz
Journal:  BMJ       Date:  2010-07-07

6.  Meta-Analysis of CSF Diversion Procedures and Dural Venous Sinus Stenting in the Setting of Medically Refractory Idiopathic Intracranial Hypertension.

Authors:  S R Satti; L Leishangthem; M I Chaudry
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

Review 7.  Headache and the pseudotumor cerebri syndrome.

Authors:  Robert M Mallery; Deborah I Friedman; Grant T Liu
Journal:  Curr Pain Headache Rep       Date:  2014-09

8.  Idiopathic intracranial hypertension and bariatric surgery: a systematic review

Authors:  Warren Y. L. Sun; Noah J. Switzer; Jerry T. Dang; Richdeep Gill; Xinzhe Shi; Christopher de Gara; Daniel Birch; Andrew Nataraj; Shahzeer Karmali
Journal:  Can J Surg       Date:  2020-03-20       Impact factor: 2.089

Review 9.  A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH).

Authors:  Aristotelis Kalyvas; Eleftherios Neromyliotis; Christos Koutsarnakis; Spyridon Komaitis; Evangelos Drosos; Georgios P Skandalakis; Mantha Pantazi; Y Pierre Gobin; George Stranjalis; A Patsalides
Journal:  Neurosurg Rev       Date:  2020-04-25       Impact factor: 3.042

10.  Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management.

Authors:  Matthew J Thurtell; Michael Wall
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.